scispace - formally typeset
J

Josep M. Antó

Researcher at Pompeu Fabra University

Publications -  523
Citations -  45951

Josep M. Antó is an academic researcher from Pompeu Fabra University. The author has contributed to research in topics: Asthma & Population. The author has an hindex of 100, co-authored 493 publications receiving 38663 citations. Previous affiliations of Josep M. Antó include University of Rochester & Centra.

Papers
More filters
Journal ArticleDOI

Correspondence on the paper by Krauss–Etschmann S, Bush A, Bellusci S, et al.

TL;DR: The authors propose a roadmap for integrative research, which aims to combine expertise in human conditions with complementary model systems to allow novel prevention strategies to promote healthy ageing.
Journal ArticleDOI

Patient‐centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA‐EAACI approach – ARIA‐EAACI Task Force Report

Jean Bousquet, +106 more
- 11 Apr 2023 - 
TL;DR: In this article , the authors developed a Task Force aimed at proposing patientreported outcome measures (PROMs) as digital biomarkers that can be easily used for different purposes in rhinitis and asthma.
Journal ArticleDOI

Comparison of outcome measures in patients with COPD

TL;DR: It is found that the St George’s Respiratory Questionnaire (SGRQ) lower than those observed in other questionnaires completed by patients with COPD attending an outpatient clinic, but an alternative explanation may lie on some methodological limitations of the study.
Journal ArticleDOI

Resumen ejecutivo de ARIA 2019: vías integradas de atención para la rinitis alérgica en Argentina, España y México

Juan Carlos Ivancevich, +52 more
TL;DR: Next-generation ARIA guidelines are being developed for the pharmacological treatment of allergic rhinitis (AR), using the GRADE-based guidelines for AR, tested with real-life evidence provided by mobile technology with visual analogue scales and concluded that in the AR treatment, H1-antihistamines are less effective than intranasal corticosteroids (INCS).